MarketWatch Automation
Shares of Corbus Pharmaceuticals Holdings Inc. /zigman2/quotes/201549545/lastsale CRBP +6.04% advanced 4.76% to $0.44 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +0.31% rising 3.41% to 14,239.88 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.41% rising 1.17% to 35,131.86. This was the stock's second consecutive day of gains. Corbus Pharmaceuticals Holdings Inc. closed $3.56 short of its 52-week high ($4.00), which the company reached on February 11th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Fate Therapeutics Inc. /zigman2/quotes/209623007/composite FATE +3.06% rose 13.32% to $41.51, Vanda Pharmaceuticals Inc. /zigman2/quotes/200957783/composite VNDA +1.96% rose 2.85% to $15.16, and Viking Therapeutics Inc. /zigman2/quotes/204618964/composite VKTX -4.12% rose 3.63% to $3.71. Trading volume (1.2 M) eclipsed its 50-day average volume of 989,779.
Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
Add to watchlist
CRBP
Add to watchlist
DJIA
Add to watchlist
FATE
Add to watchlist
VNDA
Add to watchlist
VKTX
